In 2016, funding for HIV prevention R&D decreased by 3 percent (US$35 million) from the previous year, falling to US$1.17 billion. Funding in 2016 signals the lowest annual investment in HIV prevention R&D in more than a decade.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!